Northstar Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$711K Sell
9,904
-394
-4% -$30.4K 0.1% 89
2025
Q4
$817K Sell
10,298
-15
-0.1% -$1.18K 0.11% 81
2025
Q3
$778K Sell
10,313
-1,377
-12% -$94.4K 0.11% 81
2025
Q2
$806K Buy
11,690
+14
+0.1% +$918 0.12% 80
2025
Q1
$791K Sell
11,676
-533
-4% -$31.9K 0.13% 74
2024
Q4
$548K Sell
12,209
-85
-0.7% -$4.77K 0.09% 87
2024
Q3
$773K Sell
12,294
-2,665
-18% -$155K 0.13% 74
2024
Q2
$883K Sell
14,959
-260
-2% -$16.3K 0.17% 69
2024
Q1
$1.21M Sell
15,219
-926
-6% -$70.7K 0.24% 59
2023
Q4
$1.27M Sell
16,145
-1,921
-11% -$137K 0.28% 58
2023
Q3
$1.26M Sell
18,066
-3,481
-16% -$247K 0.3% 58
2023
Q2
$1.49M Sell
21,547
-797
-4% -$56.7K 0.35% 55
2023
Q1
$1.66M Buy
22,344
+22
+0.1% +$1.84K 0.43% 52
2022
Q4
$2.08M Buy
22,322
+488
+2% +$47.1K 0.59% 42
2022
Q3
$2.08M Buy
21,834
+113
+0.5% +$11.2K 0.62% 36
2022
Q2
$2.01M Sell
21,721
-63
-0.3% -$6.15K 0.58% 40
2022
Q1
$2.21M Sell
21,784
-638
-3% -$67K 0.53% 43
2021
Q4
$2.31M Sell
22,422
-186
-0.8% -$17.2K 0.55% 45
2021
Q3
$1.92M Sell
22,608
-797
-3% -$66.8K 0.5% 48
2021
Q2
$1.95M Buy
23,405
+36
+0.2% +$2.95K 0.51% 47
2021
Q1
$1.76M Sell
23,369
-3,109
-12% -$226K 0.5% 50
2020
Q4
$1.81M Buy
26,478
+3,094
+13% +$201K 0.55% 46
2020
Q3
$1.37M Buy
23,384
+3,089
+15% +$192K 0.47% 54
2020
Q2
$1.32M Sell
20,295
-1,159
-5% -$73K 0.53% 48
2020
Q1
$1.27M Sell
21,454
-241
-1% -$16.1K 0.58% 45
2019
Q4
$1.61M Sell
21,695
-50
-0.2% -$3.51K 0.62% 45
2019
Q3
$1.37M Sell
21,745
-792
-4% -$46.9K 0.57% 49
2019
Q2
$1.23M Sell
22,537
-268
-1% -$14.4K 0.52% 51
2019
Q1
$1.23M Buy
22,805
+67
+0.3% +$4.13K 0.55% 48
2018
Q4
$1.49M Buy
22,738
+295
+1% +$22K 0.76% 34
2018
Q3
$1.77M Sell
22,443
-151
-0.7% -$10.8K 0.81% 34
2018
Q2
$1.45M Buy
22,594
+36
+0.2% +$2.37K 0.74% 38
2018
Q1
$1.4M Sell
22,558
-569
-2% -$40.8K 0.73% 39
2017
Q4
$1.66M Sell
23,127
-2,198
-9% -$160K 0.87% 34
2017
Q3
$2.06M Sell
25,325
-162
-0.6% -$12.8K 1.19% 22
2017
Q2
$2.05M Buy
25,487
+37
+0.1% +$2.92K 1.26% 21
2017
Q1
$1.98M Sell
25,450
-2,553
-9% -$204K 1.31% 16
2016
Q4
$2.12M Buy
28,003
+1,907
+7% +$154K 1.46% 16
2016
Q3
$2.33M Buy
26,096
+6,656
+34% +$628K 1.67% 14
2016
Q2
$1.86M Buy
19,440
+21
+0.1% +$2.09K 1.39% 18
2016
Q1
$2.01M Sell
19,419
-4
-0% -$389 1.54% 15
2015
Q4
$1.9M Buy
19,423
+571
+3% +$55.9K 1.51% 16
2015
Q3
$1.86M Sell
18,852
-192
-1% -$20.2K 1.52% 14
2015
Q2
$2M Buy
19,044
+223
+1% +$22.8K 1.52% 15
2015
Q1
$1.94M Sell
18,821
-33
-0.2% -$3.34K 1.5% 15
2014
Q4
$1.82M Buy
+18,854
New +$1.66M 1.42% 15

Other funds holding CVS

Northstar Group's CVS Position: Q1 2026 in Review

Northstar Group reduced its CVS Health (CVS) stake by 3.8% in Q1 2026, selling an estimated $30.4K and leaving 9,904 shares worth $711K. The position accounts for 0.1% of the portfolio, ranked #89.

Northstar Group first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.33M in Q3 2016. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Northstar Group held 9,904 shares of CVS Health worth $711K as of Q1 2026.
  • Northstar Group sold 394 CVS Health shares in Q1 2026, an estimated $30.4K.
  • CVS Health made up 0.1% of Northstar Group's portfolio in Q1 2026, its #89 holding.
  • Northstar Group first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • Northstar Group's CVS Health position peaked at $2.33M in Q3 2016.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.